Sector: Basic Materials | Industry: Agricultural Chemicals |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 4695 Macarthur Ct NEWPORT BEACH CA 92660-1882 |
Tel: | 1-949-2601200 |
Website: | https://www.american-vanguard.com |
IR: | See website |
Key People | ||
Eric G. Wintemute Chairman of the Board, Chief Executive Officer | David T. Johnson Chief Financial Officer, Vice President, Treasurer | Ulrich G. Trogele Executive Vice President, Chief Operating Officer of AMVAC Chemical Corporation |
Anthony S. Hendrix Senior Vice President - Crop Sales, U.S. and Canada | Shirin Khosravi Senior Vice President of Human Resources | Timothy J. Donnelly Chief Administrative Officer, General Counsel, Secretary |
Peter E. Eilers Managing Director of AMVAC Netherlands BV | Don Gualdoni Chief Transformation Officer |
Business Overview |
American Vanguard Corporation is a diversified specialty and agricultural products company. The Company develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. The Company conducts its business through its operating subsidiaries, including AMVAC Chemical Corporation (AMVAC) for its domestic business and AMVAC Netherlands BV (AMVAC BV) for its international business. AMVAC manufactures chemical, biological and biorational products that develop and markets solutions for agricultural, commercial and consumer uses. Its products include insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals, and are marketed in liquid, powder, and granular forms. AMVAC BV sells products both directly and through its network of subsidiaries in various international territories. It also manufactures microbial cleaning products, BioMop-Plus and DrainGel. |
Financial Overview |
For the fiscal year ended 31 December 2023, American Vanguard Corp. revenues decreased 5% to $579.4M. Net income decreased 73% to $7.5M. Revenues reflect United States segment decrease of 6% to $344.5M, International segment decrease of 4% to $234.9M. Net income also reflects Interest Expense, net - Balancing value increase from $4.3M to $13.2M (expense), Research, product development increase of 20% to $38M (expense). |
Employees: | 845 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $462.95M as of Dec 31, 2023 |
Annual revenue (TTM): | $579.37M as of Dec 31, 2023 |
EBITDA (TTM): | $46.03M as of Dec 31, 2023 |
Net annual income (TTM): | $7.52M as of Dec 31, 2023 |
Free cash flow (TTM): | -$74.20M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $127.48M as of Dec 31, 2023 |
Shares outstanding: | 28,795,082 as of Mar 5, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |